Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maxirich
- Development stage
- Unknown
- Lead developer
- Cipla Health
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Maxirich is a multivitamin and multimineral supplement brand developed and marketed by Cipla Health. The primary formulation, often referred to as Maxirich Daily Multivitamin or Maxirich Gold, is designed to supplement nutritional intake, boost energy levels, and support overall health. It typically contains a comprehensive blend of essential vitamins (such as A, B-complex, C, D3, and E) and minerals (including zinc, iron, and magnesium), often supplemented with Panax Ginseng extract to enhance physical stamina and mental alertness. It is positioned as an over-the-counter (OTC) consumer healthcare product to address micronutrient deficiencies and support immune function.
- Brand names
- MaxirichMaxirich GoldMaxirich Daily MultivitaminMaxirich Vitamin C+
- Other names
- Maxirich Multivitamin
02
Targets
VDR (Vitamin D receptor)RAR (Retinoic acid receptor)
Beyond the preview
Go deeper on Maxirich.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maxirich.